Table 4 Efficacy results during VEM1-IPI

Best overall response, n (%)

 Complete response

2 (4.3)

 Partial response

13 (28.3)

 Stable disease

5 (10.9)

 Progressive disease

11 (23.9)

 Unknown^a

15 (32.6)

Best overall response rate, % (95 % CI)

32.6 (19.5–48.0)

Median duration of response, mo (95 % CI)

23.1 (5.03–NE)

Median duration of stable disease, mo (95 % CI)

5.2 (3.98–14.75)